awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24607170-80457F17-8739-440D-A76D-B5812220332C
Q24607170-80457F17-8739-440D-A76D-B5812220332C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24607170-80457F17-8739-440D-A76D-B5812220332C
Updates of mTOR inhibitors
P2860
Q24607170-80457F17-8739-440D-A76D-B5812220332C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24607170-80457F17-8739-440D-A76D-B5812220332C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f8daec8b642687d419a8cef187bc9426722d09eb
P2860
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (